Abyrx
-
Biologics
Abyrx Receives Additional FDA Clearances for MONTAGE® Settable, Resorbable Bone Putty as Bone Void Filler and Cranial Bone Cement
STAMFORD, Conn., April 5, 2023 /PRNewswire/ — Abyrx, Inc. (http://abyrx.com), a leading biomaterial sciences company with a focus on therapeutic technologies for…
Read More » -
Financial
Abyrx® Announces Expansion of Exclusive, Worldwide License Agreement with Bezwada Biomedical; Completes $10M Equity Financing.
IRVINGTON, N.Y., Dec. 6, 2016 /PRNewswire/ — Abyrx®, Inc., a privately-held specialty biosurgical products company, today announced the expansion of its exclusive, worldwide…
Read More »